← Leaderboards
Hailing Lu
University Of Washington
$1,061,413
Attributed
$1,061,413
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $287.9K · FY2010–13$500K$375K$250K$125K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$1,061,413 · 1
By mechanism
R01$1,061,413 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Washington
Same institution · by research overlap
- Mary L. Disis$210,448,010
- Philip D Greenberg$22,941,903
- William A Altemeier$7,061,227
- Elizabeth Ann Misch$753,400
- Pamela J Fink$12,911,564
Others in their field
Top investigators on “Agonist”
- John M Lachin · George Washington University$118,921,924
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Alan G. Barbour · University Of California Irvine$40,092,035
- Alexandros Makriyannis · University Of Connecticut Storrs$29,942,402
- Scott T Weiss · University Of California, San Diego$28,624,344
- John Didsbury · T3d Therapeutics, Inc.$25,150,614
Research focus
AgonistAntibody -Dependent Cell CytotoxicityAntigensAntineoplastic AgentsAsiaAxillaBaseBiomarkerBreastCaliberChemotherapyChest Wall StructureClinical ManagementComplementary And Alternative MedicineDeveloping CountriesEnrollmentErbb2 GeneEvaluationFight AgainstFoundationsGenerationsHigh RiskImmuneAgaricales
Grant awards (4)
PSK as Neoadjuvant Therapy for Locally Advanced Breast Cancer$247,259
R01 · FY2013 · CA · contact PI
PSK as Neoadjuvant Therapy for Locally Advanced Breast Cancer$263,042
R01 · FY2012 · CA · contact PI
PSK as Neoadjuvant Therapy for Locally Advanced Breast Cancer$263,235
R01 · FY2011 · CA · contact PI
PSK as Neoadjuvant Therapy for Locally Advanced Breast Cancer$287,877
R01 · FY2010 · CA · contact PI